Cargando…
Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy
BACKGROUND: We estimated the number of women undergoing cervical cancer screening annually in Italy, the rates of cervical abnormalities detected, and the costs of screening and management of abnormalities. METHODS: The annual number of screened women was estimated from National Health Interview dat...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651166/ https://www.ncbi.nlm.nih.gov/pubmed/19243586 http://dx.doi.org/10.1186/1471-2458-9-71 |
_version_ | 1782165143632740352 |
---|---|
author | Rossi, Paolo Giorgi Ricciardi, Alessandro Cohet, Catherine Palazzo, Fabio Furnari, Giacomo Valle, Sabrina Largeron, Nathalie Federici, Antonio |
author_facet | Rossi, Paolo Giorgi Ricciardi, Alessandro Cohet, Catherine Palazzo, Fabio Furnari, Giacomo Valle, Sabrina Largeron, Nathalie Federici, Antonio |
author_sort | Rossi, Paolo Giorgi |
collection | PubMed |
description | BACKGROUND: We estimated the number of women undergoing cervical cancer screening annually in Italy, the rates of cervical abnormalities detected, and the costs of screening and management of abnormalities. METHODS: The annual number of screened women was estimated from National Health Interview data. Data from the Italian Group for Cervical Cancer Screening were used to estimate the number of positive, negative and unsatisfactory Pap smears. The incidence of CIN (cervical intra-epithelial neoplasia) was estimated from the Emilia Romagna Cancer Registry. Patterns of follow-up and treatment costs were estimated using a typical disease management approach based on national guidelines and data from the Italian Group for Cervical Cancer Screening. Treatment unit costs were obtained from Italian National Health Service and Hospital Information System of the Lazio Region. RESULTS: An estimated 6.4 million women aged 25–69 years undergo screening annually in Italy (1.2 million and 5.2 million through organized and opportunistic screening programs, respectively). Approximately 2.4% of tests have positive findings. There are approximately 21,000 cases of CIN1 and 7,000–17,000 cases of CIN2/3. Estimated costs to the healthcare service amount to €158.5 million for screening and €22.9 million for the management of cervical abnormalities. CONCLUSION: Although some cervical abnormalities might have been underestimated, the total annual cost of cervical cancer prevention in Italy is approximately €181.5 million, of which 87% is attributable to screening. |
format | Text |
id | pubmed-2651166 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-26511662009-03-05 Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy Rossi, Paolo Giorgi Ricciardi, Alessandro Cohet, Catherine Palazzo, Fabio Furnari, Giacomo Valle, Sabrina Largeron, Nathalie Federici, Antonio BMC Public Health Research Article BACKGROUND: We estimated the number of women undergoing cervical cancer screening annually in Italy, the rates of cervical abnormalities detected, and the costs of screening and management of abnormalities. METHODS: The annual number of screened women was estimated from National Health Interview data. Data from the Italian Group for Cervical Cancer Screening were used to estimate the number of positive, negative and unsatisfactory Pap smears. The incidence of CIN (cervical intra-epithelial neoplasia) was estimated from the Emilia Romagna Cancer Registry. Patterns of follow-up and treatment costs were estimated using a typical disease management approach based on national guidelines and data from the Italian Group for Cervical Cancer Screening. Treatment unit costs were obtained from Italian National Health Service and Hospital Information System of the Lazio Region. RESULTS: An estimated 6.4 million women aged 25–69 years undergo screening annually in Italy (1.2 million and 5.2 million through organized and opportunistic screening programs, respectively). Approximately 2.4% of tests have positive findings. There are approximately 21,000 cases of CIN1 and 7,000–17,000 cases of CIN2/3. Estimated costs to the healthcare service amount to €158.5 million for screening and €22.9 million for the management of cervical abnormalities. CONCLUSION: Although some cervical abnormalities might have been underestimated, the total annual cost of cervical cancer prevention in Italy is approximately €181.5 million, of which 87% is attributable to screening. BioMed Central 2009-02-25 /pmc/articles/PMC2651166/ /pubmed/19243586 http://dx.doi.org/10.1186/1471-2458-9-71 Text en Copyright © 2009 Rossi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Rossi, Paolo Giorgi Ricciardi, Alessandro Cohet, Catherine Palazzo, Fabio Furnari, Giacomo Valle, Sabrina Largeron, Nathalie Federici, Antonio Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy |
title | Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy |
title_full | Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy |
title_fullStr | Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy |
title_full_unstemmed | Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy |
title_short | Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy |
title_sort | epidemiology and costs of cervical cancer screening and cervical dysplasia in italy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651166/ https://www.ncbi.nlm.nih.gov/pubmed/19243586 http://dx.doi.org/10.1186/1471-2458-9-71 |
work_keys_str_mv | AT rossipaologiorgi epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly AT ricciardialessandro epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly AT cohetcatherine epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly AT palazzofabio epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly AT furnarigiacomo epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly AT vallesabrina epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly AT largeronnathalie epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly AT federiciantonio epidemiologyandcostsofcervicalcancerscreeningandcervicaldysplasiainitaly |